Skip to content

Patent Law Weblog

    • About

recent posts

  • Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
  • PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
  • Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
  • United States Files Statement of Interest in Patent Infringement Proceedings
  • Supreme Court Oral Argument in Hikma v. Amarin

about

  • Twitter
  • Facebook
  • Instagram

PTAB Issues Judgment on Priority in CRISPR Interference

March 27, 2026

Despite a pointed decision by the Federal Circuit vacating and remanding the matter to the Patent Trial and Appeal Board, yesterday the Board once again granted priority for CRISPR technology to the Broad Institute. A more detailed discussion of the basis for this judgment will follow.

Judgment 37 C.F.R. § 41.127(a)Download

Share this:

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
Like Loading…
Posted in Uncategorized

Leave a comment Cancel reply

←Parties File Supplemental Priority Statements in CRISPR Interference
Judicial Conduct and Disability Committee Has Its Say, Denies Judge Newman’s Latest Request for Review→

Blog at WordPress.com.

  • Comment
  • Reblog
  • Subscribe Subscribed
    • Patent Docs
    • Join 104 other subscribers
    • Already have a WordPress.com account? Log in now.
    • Patent Docs
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Copy shortlink
    • Report this content
    • View post in Reader
    • Manage subscriptions
    • Collapse this bar
%d